Additionally, laboratory data such as Carcinoembryonic Antigen (CEA) levels, which are biomarkers for colorectal cancer, are frequently collected to monitor disease progression and response to treatment [10,11]. This evidence concerns the gene CEACAM5 and colorectal cancer.